Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.

Dolores Siedlecki-WullichJudit Català-SolsonaCristina FábregasIsabel HernándezJordi ClarimonAlberto LleóMerce BoadaCarlos A SauraJosé Rodríguez-ÁlvarezAlfredo J Miñano-Molina

Published in: Alzheimer's research & therapy (2019)

Our study shows that plasma miR-92a-3p, miR-181c-5p and miR-210-3p constitute a specific molecular signature potentially useful as a potential biomarker for AD.

Keyphrases

cell proliferation
long non coding rna
cognitive decline
prefrontal cortex